Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination

Autor: Ueli Suter, Thomas Bock, Páris N. M. Sidiropoulos, Axel Niemann, Dies Meijer, Michaela Miehe, Rohini Kuner, Carole I. Oertli, Elisa Tinelli, Bernd Wollscheid
Přispěvatelé: Molecular Genetics
Rok vydání: 2012
Předmět:
Time Factors
Receptor
ErbB-2

Dynamin II
Culture Media
Serum-Free

Mice
0302 clinical medicine
Neurofilament Proteins
Ganglia
Spinal

RNA
Small Interfering

Cells
Cultured

Genetics
Neurons
0303 health sciences
Integrin beta1
Transferrin
Cell Differentiation
Flow Cytometry
Endocytosis
3. Good health
Cell biology
Protein Transport
Gene Knockdown Techniques
Hereditary motor and sensory neuropathy
Green Fluorescent Proteins
Adaptor Protein Complex 2
Mice
Transgenic

Biology
Transfection
03 medical and health sciences
medicine
Animals
Humans
Autosomal dominant centronuclear myopathy
030304 developmental biology
Dynamin
Myelin Basic Protein
Receptor-mediated endocytosis
medicine.disease
Embryo
Mammalian

Clathrin
Myelin basic protein
Rats
DNM2
Gene Expression Regulation
Mutation
biology.protein
Charcot-Marie-Tooth disease
Myelination
Dynamin 2
Neurology (clinical)
Schwann Cells
030217 neurology & neurosurgery
Zdroj: Brain : a journal of neurology
Brain, 135, 1395-1411. Oxford University Press
Brain: A Journal of Neurology, 135 (5)
ISSN: 1460-2156
0006-8950
Popis: Mutations in dynamin 2 (DNM2) lead to dominant intermediate Charcot-Marie-Tooth neuropathy type B, while a different set of DNM2 mutations cause autosomal dominant centronuclear myopathy. In this study, we aimed to elucidate the disease mechanisms in dominant intermediate Charcot-Marie-Tooth neuropathy type B and to find explanations for the tissue-specific defects that are associated with different DNM2 mutations in dominant intermediate Charcot-Marie-Tooth neuropathy type B versus autosomal dominant centronuclear myopathy. We used tissue derived from Dnm2-deficient mice to establish an appropriate peripheral nerve model and found that dominant intermediate Charcot-Marie-Tooth neuropathy type B-associated dynamin 2 mutants, but not autosomal dominant centronuclear myopathy mutants, impaired myelination. In contrast to autosomal dominant centronuclear myopathy mutants, Schwann cells and neurons from the peripheral nervous system expressing dominant intermediate Charcot-Marie-Tooth neuropathy mutants showed defects in clathrin-mediated endocytosis. We demonstrate that, as a consequence, protein surface levels are altered in Schwann cells. Furthermore, we discovered that myelination is strictly dependent on Dnm2 and clathrin-mediated endocytosis function. Thus, we propose that altered endocytosis is a major contributing factor to the disease mechanisms in dominant intermediate Charcot-Marie-Tooth neuropathy type B.
Databáze: OpenAIRE